hafnium and Sarcoma
hafnium has been researched along with Sarcoma in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Balosso, J; Chargari, C; Porcel, E; Rodriguez-Lafrasse, C; Verry, C | 1 |
| Bourhis, J; Jumeau, R; Vilotte, F | 1 |
| Bonvalot, S; Le Péchoux, C; Wardelmann, E | 1 |
| Khalladi, N; Thariat, J | 1 |
| Nussbaum, DP | 1 |
| Agoston, P; Anghel, R; Austen, L; Bonvalot, S; Borkowska, A; Bovée, JVMG; Carrère, S; Co, A; de Baère, T; Dema, S; Ducassou, A; Gebhart, M; Gronchi, A; Helfre, S; Herraez, AC; Hohenberger, P; Hong, A; Kacso, G; Kantor, G; Lapeire, L; Lazar, AJ; Le Cesne, A; Le Péchoux, C; Li, RK; Loong, HH; Mangel, L; Mervoyer, A; Montero, A; Moreno, V; Moureau-Zabotto, L; Papai, Z; Rastrelli, M; Rutkowski, PL; Saada-Bouzid, E; Servois, V; Sunyach, MP; Sy-Ortin, T; Terrier, P; Thariat, J; Tiangco, B; Vergés, R; Wardelmann, E | 1 |
Reviews
1 review(s) available for hafnium and Sarcoma
| Article | Year |
|---|---|
[Use of nanoparticles as radiosensitizing agents in radiotherapy: State of play].
Topics: Adenocarcinoma; Brain Neoplasms; Clinical Trials, Phase I as Topic; Gadolinium; Gold; Hafnium; Humans; Lung Neoplasms; Nanomedicine; Nanoparticles; Radiation-Sensitizing Agents; Sarcoma | 2019 |
Trials
1 trial(s) available for hafnium and Sarcoma
| Article | Year |
|---|---|
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Female; Hafnium; Humans; Male; Middle Aged; Nanoparticles; Oxides; Radiation-Sensitizing Agents; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2019 |
Other Studies
4 other study(ies) available for hafnium and Sarcoma
| Article | Year |
|---|---|
High Z nanoparticles and radiotherapy: a critical view.
Topics: Hafnium; Humans; Nanoparticles; Oxides; Sarcoma | 2019 |
High Z nanoparticles and radiotherapy: a critical view - Authors' reply.
Topics: Hafnium; Humans; Nanoparticles; Oxides; Sarcoma | 2019 |
[Doubling complete histological response in sarcomas with radiation therapy using nanoparticles (Hafnium oxide, NBTXR3), a phase III trial].
Topics: Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Dose Fractionation, Radiation; Hafnium; Humans; Multicenter Studies as Topic; Nanoparticles; Organs at Risk; Oxides; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Treatment Outcome | 2019 |
Nanoparticle augmentation of radiotherapy in sarcoma.
Topics: Hafnium; Humans; Nanoparticles; Oxides; Sarcoma; Soft Tissue Neoplasms | 2019 |